22.05.2017 Views

Review of Pharmacology - 9E (2015)

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Chemotherapy A: General Consideration and Non-specific Antimicrobial Agents<br />

32. Ans. (b) Ceftriaxone (Ref: KDT 7/e p724, 727-728)<br />

33. Ans. (c) Clindamycin (Ref: KDT 7/e p712)<br />

34. Ans. (c) Tetracycline (Ref: CMDT 2014/ p1415)<br />

35. Ans. (b) Azithromycin (Ref: KDT 7/e p656)<br />

36. Ans. (d) Aztreonam (Ref: KDT 7/e p724)<br />

37. Ans. (c) Are safe in pregnancy (Ref: KDT 7/e 695)<br />

38. Ans. (c) Azithromycin (Ref: CMDT 2014/ p162)<br />

39. Ans. (a) Vancomycin (Ref: CMDT 2014/ p467, 1257)<br />

40. Ans. (c) Dapsone (Ref: Goodman and Gilman 12/e p1823, CMDT 2014/ p119)<br />

41. Ans. (a) Injection Benzathine pencillin 2.4 million units IM single dose (Ref: CMDT 2014/ p1258)<br />

42. Ans. (d) Imipenem (Ref: KDT 7/e p731)<br />

43. Ans. (b) Vancomycin (Ref: KDT 7/e p757)<br />

44. Ans. (b) Pseudomembranous colitis (Ref: KDT 7/e p757)<br />

45. Ans. (c) Clostridium difficile (Ref: KDT 7/e p694)<br />

46. Ans. (a) Ethambutol (Ref: KDT 7/e p769)<br />

47. Ans. (a) Quinolones (Ref: KDT 7/e p695)<br />

48. Ans. (a) Gentamicin (Ref: KDT 7/e p746)<br />

49. Ans. (c) Benzathine penicillin (Ref: KDT 7/e p720)<br />

50. Ans. (a) Quinolones (Ref: KDT 7/e p697)<br />

51. Ans. (c) Rifampin (Ref: KDT 7/e p768)<br />

52. Ans. (c) Amikacin (Ref: KDT 7/e p749)<br />

53. Ans. (c) Post antibiotic effect (Ref: KDT 7/e p697)<br />

54. Ans. (b) 30 minutes before incision (Ref: KDT 7/e p702)<br />

55. Ans. (d) Vancomycin (Ref: KDT 7/e p757)<br />

56. Ans. (c) Competitive inhibition (Ref: KDT 7/e p704)<br />

57. Ans. (c) Piperacillin (Ref: KDT 7/e p724)<br />

58. Ans. (d) Doxycycline (Ref: KDT 7/e p735)<br />

59. Ans. (b) Cotrimoxazole (Ref: KDT 7/e p708)<br />

60. Ans. (c) Cefpirome (Ref: KDT 7/e p726)<br />

61. Ans. (b) Methicillin (Ref: KDT 7/e p721)<br />

62. Ans. (d) Vancomycin (Ref: KDT 7/e p721,726,730)<br />

63. Ans. (c) Gentamicin (Ref: KDT 7/e p743)<br />

64. Ans. (a) Chloramphenicol (Ref: KDT 7/e p740)<br />

65. Ans. (d) Sparfloxacin (Ref: KDT 7/e p714)<br />

66. Ans. (a) Clindamycin (Ref: KDT 7/e p756)<br />

67. Ans. (c) Ototoxicity (Ref: KDT 7/e p745)<br />

68. Ans. (a) 95% oral bioavailability (Ref: KDT 7/e p757)<br />

69. Ans. (c) 3 mg/ml (Ref: KDT 7/e p749)<br />

70. Ans. (b) oral (Ref: KDT 7/e p757)<br />

71. Ans. (c) 2.4 MU single i.m. (Ref: KDT 7/e p763)<br />

72. Ans. (c) Tetracycline (Ref: KDT 6/e p715)<br />

Chemotherapy A: General Considerations <strong>Pharmacology</strong> and Non-specific...<br />

575<br />

https://kat.cr/user/Blink99/

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!